Publication
Serum PD-1/PD-L1 levels, tumor expression and PD-L1 somatic mutations in HER2-positive and triple negative normal-like feline mammary carcinoma subtypes
dc.contributor.author | Nascimento, Catarina | |
dc.contributor.author | Urbano, Ana Catarina | |
dc.contributor.author | Gameiro, Andreia | |
dc.contributor.author | Ferreira, João | |
dc.contributor.author | Correia, Jorge Manuel de Jesus | |
dc.contributor.author | Ferreira, Fernando | |
dc.date.accessioned | 2022-01-21T12:17:21Z | |
dc.date.available | 2022-01-21T12:17:21Z | |
dc.date.issued | 2020 | |
dc.description | © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). | pt_PT |
dc.description.abstract | Tumor microenvironment has gained great relevance due to its ability to regulate distinct checkpoints mediators, orchestrating tumor progression. Serum programmed cell death protein-1 (PD-1) and programmed death ligand-1 (PD-L1) levels were compared with healthy controls and with serum cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and tumor necrosis factor-alpha (TNF-α) levels in order to understand the role of PD-1/PD-L1 axis in cats with mammary carcinoma. PD-1 and PD-L1 expression was evaluated in tumor-infiltrating lymphocytes (TILs) and cancer cells, as the presence of somatic mutations. Results showed that serum PD-1 and PD-L1 levels were significantly higher in cats with HER2-positive (p = 0.017; p = 0.032) and triple negative (TN) normal-like mammary carcinomas (p = 0.004; p = 0.015), showing a strong positive correlation between serum CTLA-4 and TNF-α levels. In tumors, PD-L1 expression in cancer cells was significantly higher in HER2-positive samples than in TN normal-like tumors (p = 0.010), as the percentage of PD-L1-positive TILs (p = 0.037). PD-L1 gene sequencing identified two heterozygous mutations in exon 4 (A245T; V252M) and one in exon 5 (T267S). In summary, results support the use of spontaneous feline mammary carcinoma as a model for human breast cancer and suggest that the development of monoclonal antibodies may be a therapeutic strategy. | pt_PT |
dc.description.sponsorship | This research was funded by Fundação para a Ciência e a Tecnologia (Portugal) through the projects PTDC/CVT-EPI/3638/2014 and CIISA-UIDP/CVT/00276/2020. C.N. is receipt of a PhD fellowship from University of Lisbon (ref.C00191r) and A.G. is receipt of a PhD fellowship from Fundação para a Ciência e a Tecnologia (ref. SFRH/BD/132260/2017). | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Cancers (Basel). 2020 May 28;12(6):1386. PMID: 32481540; PMCID: PMC7352561 | pt_PT |
dc.identifier.doi | 10.3390/cancers12061386 | pt_PT |
dc.identifier.eissn | 2072-6694 | |
dc.identifier.uri | http://hdl.handle.net/10451/50909 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | MDPI | pt_PT |
dc.relation | CIISA-UIDP/CVT/00276/2020 | pt_PT |
dc.relation | Developing diagnostic tools for feline mammary carcinomas and improving chemotherapy based on HER2 and topoisometase status | |
dc.relation.publisherversion | https://www.mdpi.com/journal/cancers | pt_PT |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt_PT |
dc.subject | CTLA-4 | pt_PT |
dc.subject | PD-1 | pt_PT |
dc.subject | PD-L1 | pt_PT |
dc.subject | TNF-α | pt_PT |
dc.subject | Biomarkers | pt_PT |
dc.subject | Feline mammary carcinoma | pt_PT |
dc.subject | Immunotherapy | pt_PT |
dc.title | Serum PD-1/PD-L1 levels, tumor expression and PD-L1 somatic mutations in HER2-positive and triple negative normal-like feline mammary carcinoma subtypes | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.awardTitle | Developing diagnostic tools for feline mammary carcinomas and improving chemotherapy based on HER2 and topoisometase status | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FCVT-EPI%2F3638%2F2014/PT | |
oaire.awardURI | info:eu-repo/grantAgreement/FCT//SFRH%2FBD%2F132260%2F2017/PT | |
oaire.citation.issue | 6 | pt_PT |
oaire.citation.title | Cancers | pt_PT |
oaire.citation.volume | 12 | pt_PT |
oaire.fundingStream | 3599-PPCDT | |
person.familyName | Nascimento | |
person.familyName | Urbano | |
person.familyName | Gameiro | |
person.familyName | Ferreira | |
person.familyName | Jesus Correia | |
person.familyName | Ferreira | |
person.givenName | Catarina | |
person.givenName | Ana Catarina | |
person.givenName | Andreia | |
person.givenName | João António Augusto | |
person.givenName | Jorge Manuel | |
person.givenName | Fernando António da Costa | |
person.identifier | 1171660 | |
person.identifier | 1183692 | |
person.identifier.ciencia-id | B718-5199-AA36 | |
person.identifier.ciencia-id | 2317-6BE3-E5F4 | |
person.identifier.ciencia-id | EA1C-91BA-1C8B | |
person.identifier.ciencia-id | 7311-54F2-A545 | |
person.identifier.ciencia-id | F81F-D7D4-57C5 | |
person.identifier.orcid | 0000-0002-2889-4910 | |
person.identifier.orcid | 0000-0003-3755-777X | |
person.identifier.orcid | 0000-0002-1602-3552 | |
person.identifier.orcid | 0000-0002-1909-4540 | |
person.identifier.orcid | 0000-0001-5765-576X | |
person.identifier.scopus-author-id | 57215430973 | |
person.identifier.scopus-author-id | 57215434573 | |
person.identifier.scopus-author-id | 7202364133 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.identifier | http://doi.org/10.13039/501100001871 | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
project.funder.name | Fundação para a Ciência e a Tecnologia | |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |
relation.isAuthorOfPublication | 40b4c4ae-f643-4c46-9cf6-0e44e32e3f0f | |
relation.isAuthorOfPublication | 247569bb-2d87-4eed-9291-3a77986fab11 | |
relation.isAuthorOfPublication | c19be668-c4ef-4356-a972-5737132f02c0 | |
relation.isAuthorOfPublication | 38921d34-76d5-4131-a1b8-fa848ad863f5 | |
relation.isAuthorOfPublication | 543a6541-c5ca-4cb9-8cab-4fd93d51f488 | |
relation.isAuthorOfPublication | 2c22dac0-d403-4f8f-87ec-b1b7762e6d9b | |
relation.isAuthorOfPublication.latestForDiscovery | 2c22dac0-d403-4f8f-87ec-b1b7762e6d9b | |
relation.isProjectOfPublication | abc0808c-ecaf-4943-a80f-e0518090d048 | |
relation.isProjectOfPublication | b50dfa7d-c2d8-4d9c-bd55-fb3c9afb9893 | |
relation.isProjectOfPublication.latestForDiscovery | abc0808c-ecaf-4943-a80f-e0518090d048 |
Files
Original bundle
1 - 1 of 1